logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Enzyme And Transporterbased Drugdrug Interactions Progress And Future Challenges 1st Edition Susan Kadlubar

  • SKU: BELL-4391370
Enzyme And Transporterbased Drugdrug Interactions Progress And Future Challenges 1st Edition Susan Kadlubar
$ 31.00 $ 45.00 (-31%)

4.4

92 reviews

Enzyme And Transporterbased Drugdrug Interactions Progress And Future Challenges 1st Edition Susan Kadlubar instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 8.67 MB
Pages: 746
Author: Susan Kadlubar, Fred F. Kadlubar (auth.), K. Sandy Pang, A. David Rodrigues, Raimund M. Peter (eds.)
ISBN: 9781441908391, 9781441908407, 1441908390, 1441908404
Language: English
Year: 2010
Edition: 1

Product desciption

Enzyme And Transporterbased Drugdrug Interactions Progress And Future Challenges 1st Edition Susan Kadlubar by Susan Kadlubar, Fred F. Kadlubar (auth.), K. Sandy Pang, A. David Rodrigues, Raimund M. Peter (eds.) 9781441908391, 9781441908407, 1441908390, 1441908404 instant download after payment.

This volume is authored by esteemed experts in the field, and provides state-of-the art knowledge related to enzyme- and transporter-based DDIs that impact the absorption and disposition of drugs. It examines the types of DDIs, methodological approaches to evaluate and view DDIs mechanistically, bioinformatics, clinical and toxicological outcomes, and regulatory recommendations. As much as possible, the future challenges and opportunities that lie ahead are presented and discussed. Special emphases are placed on the quantitative assessment of the roles of different transporters, need for more specific probes and inhibitors, and recognition of extrahepatic eliminating organs. Future approaches should integrate transporters and enzymes to accelerate the development of physiological based-pharmacokinetic models (PBPK-DDI) and information related to inter-subject variability. In addition, the authors look beyond small molecules and consider DDIs involving biologic agents, such as therapeutic antibodies, that can bring about pharmacologically significant drug-cytokine or drug-endocrine interactions.

Related Products